These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6746897)

  • 1. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.
    Marcum JA; McKenney JB; Rosenberg RD
    J Clin Invest; 1984 Aug; 74(2):341-50. PubMed ID: 6746897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells.
    Marcum JA; Rosenberg RD
    Biochem Biophys Res Commun; 1985 Jan; 126(1):365-72. PubMed ID: 3970699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulantly active heparin-like molecules from mast cell-deficient mice.
    Marcum JA; McKenney JB; Galli SJ; Jackman RW; Rosenberg RD
    Am J Physiol; 1986 May; 250(5 Pt 2):H879-88. PubMed ID: 3706560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
    Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of the reaction between thrombin and antithrombin III by non-stoichiometric amounts of heparin.
    Björk I; Nordenman B
    Eur J Biochem; 1976 Sep; 68(2):507-11. PubMed ID: 976270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of antithrombin III with bovine aortic segments. Role of heparin in binding and enhanced anticoagulant activity.
    Stern D; Nawroth P; Marcum J; Handley D; Kisiel W; Rosenberg R; Stern K
    J Clin Invest; 1985 Jan; 75(1):272-9. PubMed ID: 3965507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the interaction of rabbit antithrombin III with the luminal surface of the normal and deendothelialized rabbit thoracic aorta in vitro.
    Hatton MW; Moar SL; Richardson M
    Blood; 1986 Apr; 67(4):878-86. PubMed ID: 3955233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous antithrombin associated with microvascular endothelium. Quantitative analysis in perfused rat hearts.
    Felsch JS; Owen WG
    Biochemistry; 1994 Jan; 33(3):818-22. PubMed ID: 8292610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
    Bourin MC
    C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin cofactor and plasma antithrombin in relation to the mechanism of inactivation of thrombin by heparin.
    Porter P; Porter MC; Shanberge JN
    Clin Chim Acta; 1967 Aug; 17(2):189-200. PubMed ID: 6035543
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH
    Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin in vertebrate species: conservation of the heparin-dependent anticoagulant mechanism.
    Jordan RE
    Arch Biochem Biophys; 1983 Dec; 227(2):587-95. PubMed ID: 6607710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III and heparin inactivation in thrombin involving reactions.
    Marciniak E
    Thromb Haemost; 1977 Aug; 38(2):486-93. PubMed ID: 579490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.
    Busch C; Owen WG
    J Clin Invest; 1982 Mar; 69(3):726-9. PubMed ID: 7061710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-reactive polypeptides of platelets may regulate inhibition of thrombin by antithrombin.
    Chelladurai M; Ganguly P
    Biochim Biophys Acta; 1986 Mar; 870(2):204-10. PubMed ID: 3955055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.